Latest news

ERS Genomics and Japan SLC sign CRISPR/Cas9 license agreement

  ERS Genomics and Japan SLC sign CRISPR/Cas9 license agreement Nobel prize winning CRISPR technology to be applied in development of genetically engineered animal models   DUBLIN, Ireland & Shizuoka, Japan, 27 July 2021: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Japan SLC, Inc., a biotechnology company providing animal models to the research community, today announced a non-exclusive license agreement granting Japan SLC access to ERS Genomics’ CRISPR/Cas9 patent portfolio. Japan SLC supports research organizations by providing animal models from its varied portfolio, including outbred,

Read more
News

Top news